Top-flight rheometer allows for outside-the-box research

Instrument maker Anton Paar has loaned Cornell a $500,000 state-of-the-art rheometer; researchers will be able to do complex experiments here instead of having to drive six hours east.

Cornell students meet, learn from COP23 world leaders

For the first week of 2017’s Conference of the Parties in Bonn, Germany, Nov. 6-17, seven Cornell students met with business and government leaders from around the world.

Strogatz's study of 'swarmalators' could direct future science

Curiosity regarding the Japanese tree frog led mathematician Steve Strogatz and a student to the study of systems that align both in time and space - which they've dubbed 'swarmalators.'

Pollack updates UA on campus climate, teacher-student policy

At a Nov. 14 University Assembly meeting, Cornell President Martha E. Pollack gave updates on issues involving campus climate and stressed the need for the university to adopt an official policy on teacher-student consensual relations by the end of the academic year.

In bee decline, fungicides emerge as improbable villain

To understand bumblebee population declines, a Cornell-led team examined environmental stressors. They found a shocker: fungicides.

Watershed moment in China examined by faculty experts

Three Cornell experts on China offered their analysis of Xi Jinping's Oct. 18 speech laying out his vision for China and consolidating his personal power.

Presidential Task Force nominations are open through Nov. 17

Nominations for the Presidential Task Force on Campus Climate opened this week: Peer nominations are due Wednesday, Nov. 15, and all self-nominations are due Friday, Nov. 17.

Binding molecule could improve injected radiation therapy

A group led by assistant professor Justin Wilson has developed a binding molecule that could improve targeted alpha-particle therapy - injected radiation treatment - for prostate cancer patients.

Study reveals why testicular cancer responds to chemo

Cornell researchers have taken a major step toward answering a key question in cancer research: Why is testicular cancer so responsive to chemotherapy, even after it metastasizes?